Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Beclomethasone After CARV Infection in Lung Transplant
NCT02351180Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2017
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic lung allograft dysfunction (CLAD) comparing Inhaled beclomethasone with Placebo (2 arms). Primary endpoints: Number of Participants Free From New or Progressive Chronic Lung Allograft Dysfunction at 180 days and Death at 180 days. Started Feb 2017; status: completed.
02
Drugs
beclomethasone
03
Conditions
chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on NCT02351180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351180.